Frontiers in Immunology · 2018 · 125 citations · 13 references
Life SciencesImmunologyMicrobiologyGastroenterologyMicrobiome ResearchTransplant ImmunologyFecal Microbiota TransplantationGut MicrobiomeGut MicrobiotaMicrobiome TherapeuticsClinical SymptomsGastrointestinal Graft-versus-host DiseaseGraft-versus-host Disease PathophysiologyGut Microbiota CompositionMicrobiome Therapeutic SafetyMicrobiome TransplantationMicrobiome-targeted TherapyPilot Study Design
Patients with steroid refractory gastrointestinal (GI) tract graft-versus-host disease (GvHD) have a poor prognosis and limited therapeutic options. To accurately assess the efficacy and safety of fecal microbiota transplantation (FMT) in treating steroid refractory GI tract GvHD, we conducted a pilot study involving eight patients. Having received FMTs, all patients' clinical symptoms improved, bacteria enriched, and microbiota composition reconstructed. They achieved a similar overall survival, and a progression-free survival better than patients who did not receive FMT. To treat steroid refractory GI tract aGvHD, FMT is efficient and safe.
13
1994 Consensus Conference on Acute GVHD Grading.
Donna Przepiorka, Daniel Weisdorf, Peyton Martin et al. · PubMed · 1995 · 5.1K citations
Duodenal Infusion of Donor Feces for Recurrent <i>Clostridium difficile</i>
Els van Nood, Anne Vrieze, Max Nieuwdorp et al. · New England Journal of Medicine · 2013 · 3.7K citations · Full text